Researchers have developed a new jab, which when injected once every two weeks into the body, can ease the crippling symptoms of arthritis.
During the year-long trial on 1,200 patients with rheumatoid arthritis, researchers found that it successfully helped improve their condition by up to 20 percent, the Daily Express reported.
According to Tanya Momtahen, irreversible joint damage can be a consequence for patients suffering from rheumatoid arthritis and this is accompanied by reduced physical function.
The new drug works by targeting a protein called IL-6 which is responsible for causing painful inflammation.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
